We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$5.41B
AUM Growth
+$138M
Cap. Flow
+$23.7M
Cap. Flow %
0.44%
Top 10 Hldgs %
64.34%
Holding
812
New
73
Increased
397
Reduced
244
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 2.57%
3 Healthcare 2.28%
4 Communication Services 1.78%
5 Consumer Discretionary 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSAC icon
701
Banco Santander Chile
BSAC
$16.4B
$195K ﹤0.01%
+10,343
New +$197K
NOK icon
702
Nokia
NOK
$52.3B
$189K ﹤0.01%
50,128
+7,144
+17% +$26.4K
JSTC icon
703
Adasina Social Justice All Cap Global ETF
JSTC
$300M
$178K ﹤0.01%
10,260
PGRE
704
DELISTED
Paramount Group
PGRE
$167K ﹤0.01%
36,018
+10,801
+43% +$50.1K
VIV icon
705
Telefônica Brasil
VIV
$20.3B
$166K ﹤0.01%
20,258
-4,803
-19% -$43.4K
CX icon
706
Cemex
CX
$17.1B
$166K ﹤0.01%
25,959
+4,832
+23% +$37K
UNFI icon
707
United Natural Foods
UNFI
$2.87B
$166K ﹤0.01%
+12,658
New +$142K
ICL icon
708
ICL Group
ICL
$6.56B
$160K ﹤0.01%
37,478
-14,129
-27% -$66.5K
VTRS icon
709
Viatris
VTRS
$20.5B
$160K ﹤0.01%
15,055
+128
+0.9% +$1.41K
CRK icon
710
Comstock Resources
CRK
$3.94B
$156K ﹤0.01%
15,058
+203
+1% +$2.13K
HBM icon
711
Hudbay
HBM
$10.4B
$146K ﹤0.01%
16,171
+3,983
+33% +$34.6K
VALE icon
712
Vale
VALE
$62B
$141K ﹤0.01%
12,640
-10,314
-45% -$124K
LRMR icon
713
Larimar Therapeutics
LRMR
$413M
$137K ﹤0.01%
+18,852
New +$144K
MD icon
714
Pediatrix Medical
MD
$2.16B
$132K ﹤0.01%
+17,509
New +$145K
ABEV icon
715
Ambev
ABEV
$47.1B
$126K ﹤0.01%
61,570
-10,625
-15% -$24.2K
ORAN
716
DELISTED
Orange
ORAN
$125K ﹤0.01%
12,495
+1,624
+15% +$18.1K
HLN icon
717
Haleon
HLN
$43.2B
$123K ﹤0.01%
14,913
-1,531
-9% -$12.8K
SBH icon
718
Sally Beauty Holdings
SBH
$1.54B
$123K ﹤0.01%
11,445
-271
-2% -$2.98K
UEC icon
719
Uranium Energy
UEC
$4.93B
$121K ﹤0.01%
20,181
+7,351
+57% +$50K
VOD icon
720
Vodafone
VOD
$35.9B
$121K ﹤0.01%
13,591
-4,167
-23% -$37.1K
HMY icon
721
Harmony Gold Mining
HMY
$10.3B
$112K ﹤0.01%
+12,237
New +$110K
VIR icon
722
Vir Biotechnology
VIR
$1.5B
$111K ﹤0.01%
12,519
-1,185
-9% -$11.4K
SSL icon
723
Sasol
SSL
$7.21B
$111K ﹤0.01%
14,596
-3,004
-17% -$22.2K
CIG icon
724
CEMIG Preferred Shares
CIG
$6.24B
$105K ﹤0.01%
59,432
+17,341
+41% +$33.2K
NOVA
725
DELISTED
Sunnova Energy
NOVA
$104K ﹤0.01%
18,559
+7,783
+72% +$37K

Similar funds

Ballentine Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ballentine Partners held 812 positions worth $5.41B, up 2.6% from $5.27B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ballentine Partners's Q2 2024 filing shows 73 new, 397 increased, 244 reduced and 59 closed positions. Its largest new stake was Forrester Research: 250,057 shares worth $4.27M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 5.6% a quarter earlier, followed by Financials and Healthcare.

  • Ballentine Partners's largest Q2 2024 buy was Forrester Research: 250,057 shares worth $4.27M.
  • Ballentine Partners added most to iShares Core MSCI EAFE ETF in Q2 2024, an estimated $11.9M increase.
  • Ballentine Partners's biggest Q2 2024 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $11.9M.
  • Ballentine Partners fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $2.57M.
  • Ballentine Partners's ten largest holdings make up 64% of its $5.41B portfolio in Q2 2024.
  • Ballentine Partners opened 73 new positions and closed 59 in Q2 2024.
  • Ballentine Partners's portfolio value rose 2.6% quarter-over-quarter to $5.41B.

Based on Ballentine Partners's 13F filing for Q2 2024, filed 6 Aug 2024.